Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00474344 · ClinicalTrials.gov registry record
Genetic Linkage Study of Idiopathic Talipes Equinovarus (ITEV) (Clubfoot)
A clinical trial, sponsored by University of British Columbia.
- Completed
- Registry status
- 370
- Enrollment target
NCT00474344: Completed study, sponsored by University of British Columbia.
NCT00474344 is a clinical trial that has completed, run by University of British Columbia. The registered enrollment target is 370 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00474344 has completed, sponsored by University of British Columbia.
- COMPLETED
- Registry status
- 370 participants
- Enrollment target
Study Summary
The goal of this study is to identify and characterize the genetic loci causing idiopathic talipes equinovarus (clubfoot). The hypothesis is that a few genes account for a substantial fraction of ITEV and that these genes can be identified in defined populations. Towards this goal, in preliminary studies, Dr. Hecht's group has identified two genes, NAT2 and CASP10, which demonstrate evidence for linkage and association to ITEV.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2004-08 |
| Est. Completion | 2013-08 |
What the finished NCT00474344 record still lists
NCT00474344 is an observational study that tracks outcomes without assigning an intervention. The registered 370 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00474344 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00474344 about?
NCT00474344 is a clinical study titled "Genetic Linkage Study of Idiopathic Talipes Equinovarus (ITEV) (Clubfoot)". The goal of this study is to identify and characterize the genetic loci causing idiopathic talipes equinovarus (clubfoot). The hypothesis is that a few genes account for a substantial fraction of ITEV and that these genes can be identified in defined populations. Towards this goal, in preliminary s...
What is the current status of trial NCT00474344?
This trial is currently completed. The enrollment target is 370 participants. The study started on 2004-08. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT00474344?
This trial is sponsored by University of British Columbia, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02332668 · 370 participants · Phase 1
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- NCT04284436 · 370 participants · NA
Study in Parkinson Disease of Exercise
- NCT05026749 · 370 participants · Phase 3
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
- NCT05125016 · 370 participants · Phase 1
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia